The first ever FDA-approved cannabis-derived product came a step nearer reality when an independent panel at the agency recommended it as a “safe” and “efficacious” treatment for childhood seizures
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields